Option Care Health (NASDAQ:OPCH) Stock Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Option Care Health stock on October 31st. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Option Care Health Price Performance

Option Care Health stock opened at $31.02 on Thursday. The stock’s 50 day moving average is $27.87 and its 200 day moving average is $29.41. Option Care Health, Inc. has a one year low of $22.29 and a one year high of $35.53. The firm has a market cap of $4.92 billion, a P/E ratio of 24.82, a P/E/G ratio of 1.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on OPCH shares. JMP Securities set a $36.00 price target on shares of Option Care Health in a research report on Friday, October 31st. Morgan Stanley assumed coverage on shares of Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price on the stock. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Finally, Cowen began coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. Nine equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $35.67.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the stock in a transaction dated Monday, November 3rd. The stock was purchased at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Norman L. Wright bought 3,411 shares of the company’s stock in a transaction dated Tuesday, September 9th. The stock was bought at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the acquisition, the director directly owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently made changes to their positions in OPCH. Cerity Partners LLC acquired a new position in shares of Option Care Health during the first quarter worth approximately $303,000. Strs Ohio bought a new stake in Option Care Health during the 1st quarter valued at $636,000. Summit Creek Advisors LLC raised its holdings in Option Care Health by 9.6% during the first quarter. Summit Creek Advisors LLC now owns 543,404 shares of the company’s stock worth $18,992,000 after buying an additional 47,747 shares during the last quarter. Prospector Partners LLC lifted its stake in shares of Option Care Health by 22.9% in the first quarter. Prospector Partners LLC now owns 111,200 shares of the company’s stock valued at $3,886,000 after buying an additional 20,700 shares in the last quarter. Finally, Andina Capital Management LLC acquired a new position in shares of Option Care Health during the first quarter valued at about $513,000. Institutional investors own 98.05% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.